Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors

BACKGROUND: Neuroendocrine tumors (NETs) overexpress somatostatin receptors (SSTRs). METHODS: We developed a second-generation, ligand-based, anti-SSTR chimeric antigen receptor (CAR) incorporating the somatostatin analog octreotide in its extracellular moiety. RESULTS: Anti-SSTR CAR T cells exerted...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandriani, Barbara, Pellè, Eleonora, Mannavola, Francesco, Palazzo, Antonio, Marsano, Renè Massimiliano, Ingravallo, Giuseppe, Cazzato, Gerardo, Ramello, Maria Cecilia, Porta, Camillo, Strosberg, Jonathan, Abate-Daga, Daniel, Cives, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240886/
https://www.ncbi.nlm.nih.gov/pubmed/35764366
http://dx.doi.org/10.1136/jitc-2022-004854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240886/
https://www.ncbi.nlm.nih.gov/pubmed/35764366
http://dx.doi.org/10.1136/jitc-2022-004854

Ejemplares similares